Rolf Mentlein researcher
Mentlein, Rolf 1948-
VIAF ID: 165537122 (Personal)
Permalink: http://viaf.org/viaf/165537122
Preferred Forms
-
- 100 1 _ ‡a Mentlein, Rolf ‡d 1948 -
- 100 1 _ ‡a Mentlein, Rolf ‡d 1948-
- 100 0 _ ‡a Rolf Mentlein ‡c researcher
4xx's: Alternate Name Forms (6)
5xx's: Related Names (4)
- 510 2 _ ‡a Christian-Albrechts-Universität zu Kiel ‡b Medizinische Fakultät ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Kiel ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Praca doktorska. Christian-Albrechts-Universität
- 510 2 _ ‡a Universität Kiel ‡b Medizinische Fakultät
Works
Title | Sources |
---|---|
Angiogenesis factors in gliomas: a new key to tumour therapy? | |
Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts. | |
The antimicrobial peptide lysozyme is induced after multiple trauma | |
ATP and adenosine induce ramification of microglia in vitro | |
Cannabinoid receptors in human astroglial tumors | |
Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells | |
CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26. | |
CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors | |
The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. | |
Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia. | |
Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16 | |
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles | |
CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). | |
CXCL12 mediates apoptosis resistance in rat C6 glioma cells. | |
CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway | |
Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells | |
Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes | |
Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. | |
Effect of transmitters and co-transmitters of the sympathetic nervous system on interleukin-6 synthesis in thymic epithelial cells | |
Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes | |
Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells. | |
Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage | |
Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors | |
Expression of stem cell markers in human astrocytomas of different WHO grades. | |
Expression of VEGF and its receptors in different brain tumors | |
Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendons. | |
Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16. | |
Glioma infiltration and extracellular matrix: key players and modulators. | |
Hydrolasen des endoplasmatischen Retikulums der Rattenleber - Enzyme mit Funktionen bei der Entgiftung und im Lipidstoffwechsel | |
Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2. | |
Iron oxide-loaded liposomes for MR imaging | |
Lost in disruption: role of proteases in glioma invasion and progression. | |
Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. | |
Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells | |
A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis | |
MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses | |
Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells | |
Multiple trauma induces serum production of host defence peptides | |
Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7. | |
Neuropeptides exert direct effects on rat thymic epithelial cells in culture | |
Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas | |
Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas | |
Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. | |
The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells. | |
Production of endogenous antibiotics in articular cartilage. | |
Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes. | |
Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells | |
The retinal pigment epithelium (RPE) induces FasL and reduces iNOS and Cox2 in primary monocytes | |
The role of Fc-receptors in the uptake and transport of therapeutic antibodies in the retinal pigment epithelium | |
The role of human beta-defensin-2 in bone | |
The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. | |
Rote Wandfarbstoffe aus Torfmoosen: Isolierung, Strukturaufklärung und Synthese | |
Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells | |
SP100 reduces malignancy of human glioma cells. | |
The splice variants 120 and 164 of the angiogenic peptide vascular endothelial cell growth factor (VEGF) are expressed during Achilles tendon healing | |
Stem cell markers in glioma progression and recurrence | |
Targeting pleiotropin to treat osteoarthritis. | |
TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease | |
The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis | |
Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity in vitro | |
Tumor risk by tissue engineering: cartilaginous differentiation of mesenchymal stem cells reduces tumor growth | |
Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells | |
Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes | |
VEGF expression in adult permanent thyroid cartilage: implications for lack of cartilage ossification | |
VEGFR-3/Flt-4 mediates proliferation and chemotaxis in glial precursor cells |